These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 12480948)

  • 1. Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid.
    Shaw-Reid CA; Munshi V; Graham P; Wolfe A; Witmer M; Danzeisen R; Olsen DB; Carroll SS; Embrey M; Wai JS; Miller MD; Cole JL; Hazuda DJ
    J Biol Chem; 2003 Jan; 278(5):2777-80. PubMed ID: 12480948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.
    Shaw-Reid CA; Feuston B; Munshi V; Getty K; Krueger J; Hazuda DJ; Parniak MA; Miller MD; Lewis D
    Biochemistry; 2005 Feb; 44(5):1595-606. PubMed ID: 15683243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-[1-(4-Fluorophenyl)methyl-1H-pyrrol-2-yl)]-2,4-dioxo-5-hexenoic acid ethyl ester a novel diketo acid derivative which selectively inhibits the HIV-1 viral replication in cell culture and the ribonuclease H activity in vitro.
    Tramontano E; Esposito F; Badas R; Di Santo R; Costi R; La Colla P
    Antiviral Res; 2005 Feb; 65(2):117-24. PubMed ID: 15708638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the ribonuclease H and DNA polymerase activities of HIV-1 reverse transcriptase by N-(4-tert-butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone.
    Borkow G; Fletcher RS; Barnard J; Arion D; Motakis D; Dmitrienko GI; Parniak MA
    Biochemistry; 1997 Mar; 36(11):3179-85. PubMed ID: 9115994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an enzymatically active ribonuclease H domain of human immunodeficiency virus type 1 reverse transcriptase.
    Stahl SJ; Kaufman JD; Vikić-Topić S; Crouch RJ; Wingfield PT
    Protein Eng; 1994 Sep; 7(9):1103-8. PubMed ID: 7530360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing and Evaluating Inhibitors against the RNase H Active Site of HIV-1 Reverse Transcriptase.
    Boyer PL; Smith SJ; Zhao XZ; Das K; Gruber K; Arnold E; Burke TR; Hughes SH
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29643235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of illimaquinone, a selective inhibitor of the RNase H activity, with the reverse transcriptases of human immunodeficiency and murine leukemia retroviruses.
    Loya S; Hizi A
    J Biol Chem; 1993 May; 268(13):9323-8. PubMed ID: 7683648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective inhibition of HIV-1 reverse transcriptase-associated ribonuclease H activity by hydroxylated tropolones.
    Budihas SR; Gorshkova I; Gaidamakov S; Wamiru A; Bona MK; Parniak MA; Crouch RJ; McMahon JB; Beutler JA; Le Grice SF
    Nucleic Acids Res; 2005; 33(4):1249-56. PubMed ID: 15741178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNase H activity: structure, specificity, and function in reverse transcription.
    Schultz SJ; Champoux JJ
    Virus Res; 2008 Jun; 134(1-2):86-103. PubMed ID: 18261820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational analysis of Tyr-501 of HIV-1 reverse transcriptase. Effects on ribonuclease H activity and inhibition of this activity by N-acylhydrazones.
    Arion D; Sluis-Cremer N; Min KL; Abram ME; Fletcher RS; Parniak MA
    J Biol Chem; 2002 Jan; 277(2):1370-4. PubMed ID: 11684697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activity of the isolated HIV RNase H domain and specific inhibition by N-hydroxyimides.
    Hang JQ; Rajendran S; Yang Y; Li Y; In PW; Overton H; Parkes KE; Cammack N; Martin JA; Klumpp K
    Biochem Biophys Res Commun; 2004 Apr; 317(2):321-9. PubMed ID: 15063760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An active recombinant p15 RNase H domain is functionally distinct from the RNase H domain associated with human immunodeficiency virus type 1 reverse transcriptase.
    Evans DB; Fan N; Swaney SM; Tarpley WG; Sharma SK
    J Biol Chem; 1994 Aug; 269(34):21741-7. PubMed ID: 7520442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate-dependent inhibition or stimulation of HIV RNase H activity by non-nucleoside reverse transcriptase inhibitors (NNRTIs).
    Hang JQ; Li Y; Yang Y; Cammack N; Mirzadegan T; Klumpp K
    Biochem Biophys Res Commun; 2007 Jan; 352(2):341-50. PubMed ID: 17113568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug targeting of HIV-1 RNA.DNA hybrid structures: thermodynamics of recognition and impact on reverse transcriptase-mediated ribonuclease H activity and viral replication.
    Li TK; Barbieri CM; Lin HC; Rabson AB; Yang G; Fan Y; Gaffney BL; Jones RA; Pilch DS
    Biochemistry; 2004 Aug; 43(30):9732-42. PubMed ID: 15274628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ribonuclease H/DNA Polymerase HIV-1 Reverse Transcriptase Dual Inhibitor: Mechanistic Studies on the Allosteric Mode of Action of Isatin-Based Compound RMNC6.
    Corona A; Meleddu R; Esposito F; Distinto S; Bianco G; Masaoka T; Maccioni E; Menéndez-Arias L; Alcaro S; Le Grice SF; Tramontano E
    PLoS One; 2016; 11(1):e0147225. PubMed ID: 26800261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.
    Hizi A; Shaharabany M; Tal R; Hughes SH
    J Biol Chem; 1992 Jan; 267(2):1293-7. PubMed ID: 1370463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting into the Substrate Dominance: Pharmacophore and Structure-Based Approaches toward Inhibiting Human Immunodeficiency Virus Reverse Transcriptase-Associated Ribonuclease H.
    Wang L; Sarafianos SG; Wang Z
    Acc Chem Res; 2020 Jan; 53(1):218-230. PubMed ID: 31880912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quinolinonyl Non-Diketo Acid Derivatives as Inhibitors of HIV-1 Ribonuclease H and Polymerase Functions of Reverse Transcriptase.
    Messore A; Corona A; Madia VN; Saccoliti F; Tudino V; De Leo A; Ialongo D; Scipione L; De Vita D; Amendola G; Novellino E; Cosconati S; Métifiot M; Andreola ML; Esposito F; Grandi N; Tramontano E; Costi R; Di Santo R
    J Med Chem; 2021 Jun; 64(12):8579-8598. PubMed ID: 34106711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ribonuclease H activity of HIV-1 reverse transcriptase: further biochemical characterization and search of inhibitors.
    Andréola ML; Tharaud D; Litvak S; Tarrago-Litvak L
    Biochimie; 1993; 75(1-2):127-34. PubMed ID: 7684932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of the ribonuclease H activity of HIV-1 reverse transcriptase by GSK5750 correlates with slow enzyme-inhibitor dissociation.
    Beilhartz GL; Ngure M; Johns BA; DeAnda F; Gerondelis P; Götte M
    J Biol Chem; 2014 Jun; 289(23):16270-7. PubMed ID: 24719329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.